Cranberry Enhances Human Immune Function and Reduces Illness
NCT ID: NCT01398150
Last Updated: 2011-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2009-03-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cranberry Consumption Improves γδ T Cell Function
NCT01713829
Effect of a Single Dose of Cranberry Beverage on Inflammation and Oxidative Stress
NCT01780922
Cranberry Ingestion and Cycling Related Immunity and Inflammation
NCT05407701
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
NCT03957239
Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress
NCT01527617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sweetened Beverage
looks like and is given in the same way as the experimental treatment but contains no active ingredient
Beverage made to look like the cranberry beverage
one 15 ounce bottle of beverage consumed daily
Cranberry Beverage
15 ounce bottle of cranberry beverage consumed daily for 70 days
Beverage made from cranberry compounds
one 15 ounce bottle consumed daily for 70 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beverage made to look like the cranberry beverage
one 15 ounce bottle of beverage consumed daily
Beverage made from cranberry compounds
one 15 ounce bottle consumed daily for 70 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 21 and 50
* BMI between 18 and 35
Exclusion Criteria
* Ongoing or chronic illness or infection
* On hypertensive medication, immunosuppressive drugs, antibiotics, or chronic use of NSAIDS
* Taking plant-based dietary supplements, antioxidant supplements, or probiotics
* Vegetarian or strict vegan
* Consume more than 1 cup of tea (iced or hot) per day
* Consumes more than 2 glasses of alcoholic beverages per day
* Consume more than 7 fruits and vegetables per day
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ocean Spray, Inc.
INDUSTRY
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan S Percival, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
449 Food Science and Human Nutrition Department
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nantz MP, Rowe CA, Muller C, Creasy R, Colee J, Khoo C, Percival SS. Consumption of cranberry polyphenols enhances human gammadelta-T cell proliferation and reduces the number of symptoms associated with colds and influenza: a randomized, placebo-controlled intervention study. Nutr J. 2013 Dec 13;12:161. doi: 10.1186/1475-2891-12-161.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CB-79545
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.